The EMRG Consortium: a gate to identify the burden of metabolic (dysfunction)-associated fatty liver disease in Egypt.
作者信息
Fouad Yasser, Gomaa Ahmed, Attia Dina
机构信息
Department of Gastroenterology, Hepatology and Endemic Medicine, Faculty of Medicine, Minia University, Main Road, Minia 11432, Egypt.
Department of Hepatology and Gastroenterology, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
出版信息
Ther Adv Endocrinol Metab. 2021 Oct 28;12:20420188211054678. doi: 10.1177/20420188211054678. eCollection 2021.
Abstract
摘要
相似文献
1
The EMRG Consortium: a gate to identify the burden of metabolic (dysfunction)-associated fatty liver disease in Egypt.EMRG联盟：识别埃及代谢（功能障碍）相关脂肪性肝病负担的一扇门。
Ther Adv Endocrinol Metab. 2021 Oct 28;12:20420188211054678. doi: 10.1177/20420188211054678. eCollection 2021.
2
Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study.代谢功能障碍相关脂肪性肝病与心血管疾病发病风险：一项全国性队列研究。
Clin Gastroenterol Hepatol. 2021 Oct;19(10):2138-2147.e10. doi: 10.1016/j.cgh.2020.12.022. Epub 2020 Dec 22.
3
Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease.经活检证实的代谢相关脂肪性肝病患者的临床和组织学特征。
Gut Liver. 2021 May 15;15(3):451-458. doi: 10.5009/gnl20218.
4
Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study.中国城市人群代谢相关脂肪性肝病的流行情况及其危险因素：一项横断面对比研究。
BMC Gastroenterol. 2021 May 10;21(1):212. doi: 10.1186/s12876-021-01782-w.
5
Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease.韩国代谢相关脂肪性肝病患者肠道微生物组的特征。
Nutrients. 2021 Mar 21;13(3):1013. doi: 10.3390/nu13031013.
6
Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight.2019冠状病毒病在肥胖人群中的严重程度：代谢功能障碍相关脂肪性肝病成为焦点。
World J Gastroenterol. 2021 Apr 28;27(16):1738-1750. doi: 10.3748/wjg.v27.i16.1738.
7
Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Children and Adolescents: Systematic Review and Meta-Analysis.评估超重或肥胖儿童和青少年代谢功能障碍相关脂肪性肝病的全球患病率：系统评价和荟萃分析。
Int J Public Health. 2021 Oct 6;66:1604371. doi: 10.3389/ijph.2021.1604371. eCollection 2021.
8
The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis.代谢功能障碍相关脂肪性肝病的进展和消退与亚临床动脉粥样硬化的发生有关：一项前瞻性分析。
Metabolism. 2021 Jul;120:154779. doi: 10.1016/j.metabol.2021.154779. Epub 2021 Apr 23.
9
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-A Condition Associated with Heightened Sympathetic Activation.代谢相关脂肪性肝病（MAFLD）——一种与交感神经激活增强相关的疾病。
Int J Mol Sci. 2021 Apr 19;22(8):4241. doi: 10.3390/ijms22084241.
10
Clinic-pathological features of metabolic associated fatty liver disease with hepatitis B virus infection.代谢相关脂肪性肝病合并乙型肝炎病毒感染的临床病理特征
World J Gastroenterol. 2021 Jan 28;27(4):336-344. doi: 10.3748/wjg.v27.i4.336.
本文引用的文献
1
Change from NAFLD to MAFLD increases the awareness of fatty liver disease in primary care physicians and specialists.从非酒精性脂肪性肝病（NAFLD）到代谢功能障碍相关脂肪性肝病（MAFLD）的转变提高了基层医疗医生和专科医生对脂肪性肝病的认识。
J Hepatol. 2021 May;74(5):1254-1256. doi: 10.1016/j.jhep.2020.12.035. Epub 2021 Feb 11.
2
Endorsing the redefinition of fatty liver disease.认可脂肪性肝病的重新定义。
Lancet Gastroenterol Hepatol. 2021 Mar;6(3):163. doi: 10.1016/S2468-1253(21)00002-9.
3
Looking for a new name for non-alcoholic fatty liver disease in Spanish: esteatosis hepática metabólica (EHmet).寻找西班牙语中非酒精性脂肪性肝病的新名称：代谢性肝脂肪变性（EHmet）。
Rev Esp Enferm Dig. 2021 Mar;113(3):161-163. doi: 10.17235/reed.2021.7862/2021.
4
Capturing patient experience: A qualitative study of change from NAFLD to MAFLD real-time feedback.捕捉患者体验：一项关于从非酒精性脂肪性肝病到代谢功能障碍相关脂肪性肝病实时反馈变化的定性研究
J Hepatol. 2021 May;74(5):1261-1262. doi: 10.1016/j.jhep.2021.01.022. Epub 2021 Jan 23.
5
The sub-Saharan Africa position statement on the redefinition of fatty liver disease: From NAFLD to MAFLD.撒哈拉以南非洲关于脂肪肝疾病重新定义的立场声明：从非酒精性脂肪性肝病到代谢相关脂肪性肝病
J Hepatol. 2021 May;74(5):1256-1258. doi: 10.1016/j.jhep.2021.01.015. Epub 2021 Jan 20.
6
From NAFLD to MAFLD: Nurse and allied health perspective.从非酒精性脂肪性肝病到代谢功能障碍相关脂肪性肝病：护士及相关健康专业人员的视角
Liver Int. 2021 Apr;41(4):683-691. doi: 10.1111/liv.14788. Epub 2021 Feb 2.
7
The NAFLD-MAFLD debate: Eminence vs evidence.非酒精性脂肪性肝病-代谢功能障碍相关脂肪性肝病之争：权威观点与证据较量
Liver Int. 2021 Feb;41(2):255-260. doi: 10.1111/liv.14739. Epub 2020 Dec 2.
8
Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa.代谢相关脂肪性肝病的命名与定义：中东和北非地区的共识
Lancet Gastroenterol Hepatol. 2021 Jan;6(1):57-64. doi: 10.1016/S2468-1253(20)30213-2. Epub 2020 Nov 9.
9
The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease.拉丁美洲肝脏研究学会（ALEH）关于重新定义脂肪肝疾病的立场声明。
Lancet Gastroenterol Hepatol. 2021 Jan;6(1):65-72. doi: 10.1016/S2468-1253(20)30340-X. Epub 2020 Nov 9.
10
Redefining fatty liver disease: an international patient perspective.重新定义脂肪肝疾病：国际患者视角。
Lancet Gastroenterol Hepatol. 2021 Jan;6(1):73-79. doi: 10.1016/S2468-1253(20)30294-6. Epub 2020 Oct 5.
Zotero 插件